Elixinol Wellness Limited
ELLXF
$0.012
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 336.90K | 346.40K | -908.10K | -906.20K | -1.34M |
| Total Depreciation and Amortization | 164.50K | 169.20K | 176.90K | 176.60K | 108.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.00K | 75.00K | 24.40K | 24.30K | -108.80K |
| Change in Net Operating Assets | -1.01M | -1.03M | -- | -- | 641.30K |
| Cash from Operations | -431.40K | -443.60K | -706.80K | -705.30K | -698.60K |
| Capital Expenditure | -4.90K | -5.00K | -14.80K | -14.80K | -3.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 10.40K |
| Cash Acquisitions | -153.50K | -157.80K | -593.10K | -591.90K | 62.60K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 746.30K | 744.80K | -99.10K |
| Cash from Investing | -158.30K | -162.80K | 138.40K | 138.10K | -29.70K |
| Total Debt Issued | 430.50K | 430.50K | -- | -- | 150.00K |
| Total Debt Repaid | -434.50K | -434.50K | -86.00K | -86.00K | -197.50K |
| Issuance of Common Stock | 747.50K | 747.50K | 1.58M | 1.58M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -84.50K | -84.50K | -197.50K | -197.50K | 0.00 |
| Cash from Financing | 429.40K | 441.60K | 855.70K | 853.90K | -31.00K |
| Foreign Exchange rate Adjustments | -2.30K | -2.30K | -1.00K | -1.00K | -1.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -162.60K | -167.20K | 286.30K | 285.70K | -760.90K |